Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
- Sponsor
- University Hospital, Toulouse
- Study ID
- NCT05251415
- Status
- Recruiting
Conditions
- Inflammatory Bowel Diseases
- Lupus Erythematosus
- Myositis
- Scleroderma
- Vasculitis
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- Blood sampling — BIOLOGICALBlood will be taken in larger quantity.
Study Details
The aim of this project is to start a biological and clinical collection of patients presenting systemic autoimmune disease. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies
Key Dates
- Start date
- Apr 4, 2022
- Status verified
- Mar 2026
- Primary completion
- Apr 4, 2027
- Completion
- Apr 4, 2032
Study Design
- Enrollment
- 3,000 participants (estimated)
Arms
- Arm: patients suffering from autoimmune diseaseBiological samples will be collected in the normal diagnosis and follow-up process. Only blood will be taken in larger quantity.
Primary Outcome Measure
Constitution of a collection of biological samples and clinical-biological data from patients with autoimmune diseases [ Time Frame: through study completion, an average of 1 year ]
Central Contacts
- Chloé BOST, MD, PhD5 61 77 61 44
Related Studies
- Cutaneous Lupus RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Miami, Florida
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruiting · University of Chicago · Chicago, Illinois
- Scleroderma Registry & Repository at the Hospital for Special SurgeryRecruiting · Hospital for Special Surgery, New York · New York, New York